| CTRI Number |
CTRI/2024/07/071336 [Registered on: 25/07/2024] Trial Registered Prospectively |
| Last Modified On: |
04/11/2024 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Process of Care Changes |
| Study Design |
Cluster Randomized Trial |
|
Public Title of Study
|
A study on effects of ALTS training for trauma physicians and its impact on in-hospital mortality. |
|
Scientific Title of Study
|
Effects of Advanced Trauma Life Support Training Compared to Standard Care on Adult Trauma Patient Outcomes A Cluster Randomised Trial |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Vivekanand Jha |
| Designation |
Executive Director |
| Affiliation |
The George Institute for Global Health, India |
| Address |
The George Institute for Global Health, India 311-312, Third Floor,
Elegance Tower Plot No. 8, Jasola District Centre
New Delhi
DELHI
India
South DELHI 110025 India |
| Phone |
911141588091 |
| Fax |
911141588090 |
| Email |
vjha@georgeinstitute.org.in |
|
Details of Contact Person Scientific Query
|
| Name |
Abhinav Bassi |
| Designation |
Co-Investigator |
| Affiliation |
The George Institute for Global Health, India |
| Address |
The George Institute for Global Health, India 311-312, Third Floor,
Elegance Tower Plot No. 8, Jasola District Centre
New Delhi
DELHI
India
South DELHI 110025 India |
| Phone |
911141588091 |
| Fax |
|
| Email |
abassi@georgeinstitute.org.in |
|
Details of Contact Person Public Query
|
| Name |
Abhinav Bassi |
| Designation |
Co-Investigator |
| Affiliation |
The George Institute for Global Health, India |
| Address |
The George Institute for Global Health, India 311-312, Third Floor,
Elegance Tower Plot No. 8, Jasola District Centre
New Delhi
DELHI
India
South DELHI 110025 India |
| Phone |
911141588091 |
| Fax |
|
| Email |
abassi@georgeinstitute.org.in |
|
|
Source of Monetary or Material Support
|
| Karolinska Institutet, 171 77 Stockholm, Sweden |
|
|
Primary Sponsor
|
| Name |
Martin Gerdin Wärnberg |
| Address |
Karolinska Institutet, 171 77 Stockholm |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 5 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Parvez David Haque |
Christian Medical College-Ludhiana |
Christian Medical College and Hospital
Brown Road Ludhiana PUNJAB |
9872630178
pdhaque@gmail.com |
| Dr Geeta Ghag |
Dr RN Cooper Hospital and HBT Medical College |
Department of General Surgery Dr RN Cooper Hospital
Juhu
Vile-Parle-West
Mumbai
Mumbai (Suburban) MAHARASHTRA |
9869381862
geetaghag@hotmail.com |
| Dr Rajeev Sharma |
Government Medical College Chandigarh |
Sector-32 Chandigarh Chandigarh CHANDIGARH |
91-172-2601023
rjvsharma63@gmail.com |
| Dr Hemant Nautiyal |
Himalayan Institute of Medical Sciences |
Himalayan Institute of Medical Sciences
Swami Ram Nagar
Jollygrant Dehradun
Dehradun
Dehradun UTTARANCHAL |
9410507100
drnauty1@gmail.com |
| Dr Amit Roy |
Nilratan Sircar Medical College & Hospital |
138 Acharya Jagdish Chandra Bose Rd Sealdah Raja Bazar Kolkata West Bengal
700014 India Kolkata WEST BENGAL |
9830403360
amitranjushree@gmail.com |
|
Details of Ethics Committee
Modification(s)
|
| No of Ethics Committees= 6 |
| Name of Committee |
Approval Status |
| Ethics Committee Swami Rama Himalayan University |
Approved |
| Institutional Ethics Committee Christian Medical College and Hospital |
Approved |
| Institutional Ethics Committee Govt. Medical College and Hospital Sector 32 Chandigarh |
Approved |
| INSTITUTIONAL ETHICS COMMITTEE NIL RATAN SIRCAR MEDICAL COLLEGE AND HOSPITAL |
Submittted/Under Review |
| Institutional Ethics Committee of IPGME&R |
Approved |
| Institutional Ethics Committee, HBTMC and Dr. R.N Cooper General Hospital |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: S00-T88||Injury, poisoning and certain other consequences of external causes, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Advanced Trauma Life Support® Training |
The intervention will be ATLS® training, a proprietary 2.5 day course teaching a standardised approach to trauma patient care using the concepts of a primary and secondary survey. Physicians will be trained in an accredited ATLS training facility in India. Each site will be included in the study for the total duration of 13 months with a total intervention period of 6 months. |
| Comparator Agent |
Standard care |
Standard care-meaning no formal trauma life support training.Each site will be included in the study for the total duration of 13 months with a total intervention period of 6 months. |
|
|
Inclusion Criteria
|
| Age From |
15.00 Year(s) |
| Age To |
99.00 Year(s) |
| Gender |
Both |
| Details |
1. Age of at least 15 years.
2. Present to the emergency department of participating hospitals with a history of trauma defined as having any of the reasons listed in the International Classification of Diseases chapter XX as the reason for presenting.
3. Admitted or died between arrival at the hospital and admission, or referred/transferred from the emergency department of a participating hospital to another hospital for admission.
4. Trauma occurred less than 48 hours before arrival at the hospital.
|
|
| ExclusionCriteria |
| Details |
Patients participants are excluded if they meet the following criteria:
1) present with isolated limb injuries; or
2) are directly admitted to a ward without being seen by a physician in the emergency department.
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Centralized |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| The primary outcome will be all-cause mortality. |
within 30 days of arrival at the emergency department. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| All-cause mortality |
within 24 hours and 3 months of arrival at the emergency department. |
| In-hospital mortality |
within 30 days of arrival at the emergency department. |
| Quality of life (EQ5D3L) |
within 7 days of discharge, and at 30 days and 3 months of arrival at the emergency department. |
| WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) |
within 7 days of discharge, and at 30 days and 3 months of arrival at the emergency department. |
| Return to work |
30 days and 3 months after arrival at the emergency department. |
| Length of emergency department stay |
Data on this outcome will be collected from patient hospital records. |
| Length of hospital stay |
Data on this outcome will be collected from patient hospital records. |
| Intensive care unit admission |
Data on this outcome will be collected from patient hospital records. |
| Length of intensive care unit stay |
Data on this outcome will be collected from patient hospital records. |
|
|
Target Sample Size
|
Total Sample Size="4320" Sample Size from India="4320"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
01/10/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="5" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Title: Effects of Advanced Trauma Life Support ® Training Compared to Standard Care on Adult Trauma Patient Outcomes: A Cluster Randomised Trial Rationale: Trauma is a massive global health issue. Many training programmes have been developed to help physicians in the initial management of trauma patients. Among these programmes, Advanced Trauma Life Support® (ATLS®) is the most popular, having trained over one million physicians worldwide. Despite its widespread use, there are no controlled trials showing that ATLS® improves patient outcomes. Multiple systematic reviews emphasise the need for such trials. Aim: To compare the effects of ATLS® training with standard care on outcomes in adult trauma patients. Primary Outcome: All-cause mortality within 30 days of arrival at the emergency department. Trial Design: Batched stepped-wedge cluster randomised trial in India. Trial Population: Adult trauma patients presenting to the emergency department of a participating hospital. Sample Size: 30 clusters and 4320 patients. Eligibility Criteria Hospitals are secondary or tertiary hospitals in India that admit or refer/transfer for admission at least 400 patients with trauma per year. Clusters are one or more units of physicians providing initial trauma care in the emergency department of tertiary hospitals in India. Patients participants are adult trauma patients who presents to the emergency department of participating hospitals and are admitted or transferred for admission. Intervention: The intervention will be ATLS ® training, a proprietary 2.5 day course teaching a standardised approach to trauma patient care using the concepts of a primary and secondary survey. Physicians will be trained in an accredited ATLS ® training facility in India. Ethical Consideration:s We will use an opt-out consent approach for collection of routinely recorded data. We will obtain informed consent for collection of non-routinely recorded data, such as quality of life and disability outcomes. Patients who are unconscious or lack a legally authorized representative will be included under a waiver of informed consent. Note that consent here refers to consent to data collection. Trial Period: 2024 to 2029 |